An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-5 | Issue-04
Cystatin C: A Novel Marker for Early Renal Impairment in Diabetic Patients
Manju Jha, Sonali Sharma, G G Kaushik, Priyanka Jain
Published: April 25, 2017 | 213 103
DOI: 10.36347/sjams.2017.v05i04.028
Pages: 1359-1364
Downloads
Abstract
Diabetes mellitus is a common cause of chronic kidney disease. Proteinuria in diabetics is associated with markedly reduced survival and increased risk of cardiovascular disease. The present study has been conducted to evaluate the role of serum Cystatin C in early detection of progression of chronic kidney disease in Diabetes mellitus patients. A total of one hundred and fifty type-2 diabetic patients were included in this hospital based case-control study and categorized into three groups of chronic kidney disease on the basis of estimated glomerular filtration rate and also grouped according to their urinary albumin creatinine ratio. Serum glucose, haemoglobin A1c, creatinine, cystatin C, ß-2-microglobulin, urinary creatinine and micro albumin were evaluated. Glomerular filtration rate estimations were calculated using serum creatinine and serum cystatin C. Cystatin C was found to be statistically significant when estimated glomerular filtration rate was calculated using serum creatinine and by serum cystatin C. Cystatin C predicts earlier decline in glomerular filtration rate than creatinine, urinary albumin creatinine ratio and ß2- microglobulin. Cystatin C indicates decline of glomerular filtration rate even when categorized according to chronic kidney disease staging and also exhibit early renal decline in normoalbuminuria subjects when categorized according to urinary albumin creatinine ratio.